NO-NSAIDs. Part 3: Nitric Oxide-Releasing Prodrugs of Non-steroidal Anti-inflammatory Drugs
作者:Namdev Borhade、Asif Rahimkhan Pathan、Somnath Halder、Manoj Karwa、Mini Dhiman、Venu Pamidiboina、Machhindra Gund、Jagannath Janardhan Deshattiwar、Sunil Vasantrao Mali、Nitin Janardanrao Deshmukh、Subrayan Palanisamy Senthilkumar、Parikshit Gaikwad、Santhosh Goud Tipparam、Jayesh Mudgal、Milan Chandra Dutta、Aslam Usmangani Burhan、Gajanan Thakre、Ankur Sharma、Shubhada Deshpande、Dattatraya Chandrakant Desai、Nauzer Pervez Dubash、Arun Kumar Jain、Somesh Sharma、Kumar Venkata Subrahmanya Nemmani、Apparao Satyam
DOI:10.1248/cpb.60.465
日期:——
"Safe NSAIDs," we report herein the design, synthesis and evaluation of 21 new NO-NSAIDs of commonly used NSAIDs such as aspirin, diclofenac, naproxen, flurbiprofen, ketoprofen, sulindac, ibuprofen and indomethacin. These prodrugs have NO-releasing disulfide linker attached to a parent NSAID via linkages such as an ester (compounds 9-16), a double ester (compounds 17-24), an imide (compounds 25-30)
为了继续努力发现可释放一氧化氮的新型非甾体抗炎药(NO-NSAID)作为潜在的“安全NSAID”,我们在此报告了21种常用NSAID的新NO-NSAID的设计,合成和评估。如阿司匹林,双氯芬酸,萘普生,氟比洛芬,酮洛芬,舒林酸,布洛芬和消炎痛。这些前药具有可通过诸如酯(化合物9-16),双酯(化合物17-24),酰亚胺(化合物25-30)或酰胺(化合物31)之类的键连接到母体NSAID上的释放NO的二硫键。 -33)。在这些NO-NSAID中,含酯的NO-阿司匹林(9),NO-双氯芬酸(10),NO-萘普生(11)和含酰亚胺的NO-阿司匹林(25),NO-氟比洛芬(27)和NO-酮洛芬(28)已显示出良好的口服吸收,抗炎活性和NO释放特性,并保护大鼠免受NSAID引起的胃损伤。NO-阿司匹林化合物25与等摩尔剂量的阿司匹林进一步共同评估,显示出与阿司匹林相当的剂量依赖性药代动力学,胃黏膜前